Thomas B Smith is EVP and Chief Medical Officer of COLLEGIUM PHARMACEUTICAL, INC. Currently has a direct ownership of 53,816 shares of COLL, which is worth approximately $1.73 Million. The most recent transaction as insider was on Sep 13, 2024, when has been sold 9,593 shares (Common Stock) at a price of $36.62 per share, resulting in proceeds of $351,295. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 53.8K
15.13% 3M change
72.57% 12M change
Total Value Held $1.73 Million

Thomas B Smith Transaction History

Date Transaction Value Shares Traded Shares Held Form
Sep 13 2024
SELL
Open market or private sale
$351,295 $36.62 p/Share
9,593 Reduced 15.13%
53,816 Common Stock
Feb 29 2024
SELL
Open market or private sale
$36,576 $36.76 p/Share
995 Reduced 1.54%
63,409 Common Stock
Feb 12 2024
SELL
Payment of exercise price or tax liability
$107,806 $33.7 p/Share
3,199 Reduced 4.73%
64,404 Common Stock
Feb 12 2024
BUY
Grant, award, or other acquisition
-
35,423 Added 34.38%
67,603 Common Stock
Feb 10 2023
BUY
Grant, award, or other acquisition
-
31,185 Added 50.0%
31,185 Common Stock

Also insider at

BDSI
BIODELIVERY SCIENCES INTERNATIONAL INC Healthcare
TBS

Thomas B Smith

EVP and Chief Medical Officer
Raleigh, NC

Track Institutional and Insider Activities on COLL

Follow COLLEGIUM PHARMACEUTICAL, INC and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells COLL shares.

Notify only if

Insider Trading

Get notified when an Collegium Pharmaceutical, Inc insider buys or sells COLL shares.

Notify only if

News

Receive news related to COLLEGIUM PHARMACEUTICAL, INC

Track Activities on COLL